Genome-wide association studies (GWAS) systematically analyze single-nucleotide polymorphisms (SNPs) across the genome for association with a single phenotype of interest such as a clinical diagnosis.
Decisions on regulatory approval of drugs are based typically on randomized trials observing statistically significant superiority of an experimental agent over an established standard. Recently, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results